Patent details

EP3820856 Title: C-MANNOSIDE COMPOPUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONS

Basic Information

Publication number:
EP3820856
PCT Application Number:
IB2019055806
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197692205
PCT Publication Number:
WO2020012336
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
C-MANNOSIDE COMPOPUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONS
French Title of Invention:
COMPOSÉS DE C-MANNOSIDE UTILES POUR LE TRAITEMENT D'INFECTIONS DES VOIES URINAIRES
German Title of Invention:
ZUR BEHANDLUNG VON HARNWEGSINFEKTIONEN NÜTZLICHE C-MANNOSID-VERBINDUNGEN
SPC Number:

Dates

Filing date:
08/07/2019
Grant date:
31/08/2022
EP Publication Date:
19/05/2021
PCT Publication Date:
16/01/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/08/2022
EP B1 Publication Date:
31/08/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/07/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/04/2025
 
 

Name:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Address:
GSK Medicines Research Centre Gunnels Wood Road, SG1 2NY, STEVENAGE, United Kingdom (GB)

From:
24/08/2022
 
 

Name:
Fimbrion Therapeutics, Inc.
Address:
20 South Sarah Street, Saint Louis MO 63108, United States (US)

History of Owners

From:
24/08/2022
To:
17/04/2025

Name:
GlaxoSmithKline Intellectual Property Development Limited
Address:
980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Agent

Name:
ARONOVA S.A.
From:
12/10/2022
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
JANETKA, James Walter
Address:
United States (US)

2

Name:
STRAMBEANU, Iulia
Address:
United States (US)

3

Name:
BISHOP, Michael Joseph
Address:
United States (US)

4

Name:
STEWART, Eugene L.
Address:
United States (US)

5

Name:
MCGRANE, Laurel Kathryn
Address:
United States (US)

6

Name:
COLANDREA, Vincent J.
Address:
United States (US)

7

Name:
LI, Yuehu
Address:
United States (US)

8

Name:
WIDDOWSON, Katherine Louisa
Address:
United States (US)

Priority

1

Priority Number:
201862695993 P
Priority Date:
10/07/2018
Priority Country:
United States (US)

2

Priority Number:
201862755588 P
Priority Date:
05/11/2018
Priority Country:
United States (US)

Classification

IPC classification:
C07D 309/10; A61P 31/04; A61K 31/7034;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2025/07
Publication date:
04/06/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
202235
Publication date:
31/08/2022
Description:
Grant (B1)

2

Issue number:
202328
Publication date:
12/07/2023
Description:
Document reprinted after correction (B8, B9)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20250000143A
Date Registered:
17/04/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
ARONOVA S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

1

Name:
Fimbrion Therapeutics, Inc.
Address:
20 South Sarah Street, Saint Louis MO 63108, United States (US)

2

Name:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Address:
GSK Medicines Research Centre Gunnels Wood Road, SG1 2NY, STEVENAGE, United Kingdom (GB)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/06/2025
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
12/10/2022 Power Of Attorney 1
13/10/2022 Outgoing Correspondence 1
17/04/2025 Request For Change 1
12/05/2025 Outgoing Correspondence 1